focus -WSS

focus

author：Wikipedia 2025-09-03 03:26:32 - browse：2554

Matts Take Column Illustration — Molly Ferguson for STAT

The news that the weight loss drug Wegovy reduced the risk of heart attacks and strokes in overweight volunteers opens up the door to vastly expanded use of the drug and medicines like it, known as GLP-1 medicines.

That could have a big, positive impact on public health, and it will very likely swell the coffers of the pharmaceutical companies that make these medicines, including Wegovy’s maker, Novo Nordisk, and Eli Lilly, now the most valuable drug company in history thanks largely to hopes for its GLP-1, Mounjaro. These are medicines that could save lives, make money, and perhaps reshape our culture. But they are also, we are learning, not without risk.

So what’s next?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Colonoscopy at 40? Study finds a possible benefit

hotspot

WSS

Guidelines to prevent youth baseball injuries need more muscle

Medical leaders decry Supreme Court decision on affirmative action

Medical leaders decry Supreme Court decision on affirmative action

How one medical school became remarkably diverse

Medical leaders decry Supreme Court decision on affirmative action

United colonoscopy coverage change 'may cost lives,' doctors say

hotspot

focus

knowledge

Peter Hotez and the public health issue of online harassment

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Guidelines to prevent youth baseball injuries need more muscle

Psychedelics group wrestles with new pharma identity

Virginia high school admissions case could be legal follow

With FDA staff opposed to Sarepta therapy, top official intervened

Virginia high school admissions case could be legal follow

Medicare details structure of new drug price negotiation program

In Memoriam: Notable people who died in 2023

Donald Trump's relentless attacks on special counsel Jack Smith

entertainment

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

Trump demands the U.S. pay no more for drugs than other countries … again

With FDA staff opposed to Sarepta therapy, top official intervened

Weight bias in eating disorder treatment complicated by new weight loss drugs

Supreme Court strikes down use of affirmative action

Sports medicine is finally prioritizing gender equality

hotspot

leisure time

hotspot

Wikipedia